Exagen Inc (XGN): Prakiraan wutah bathi saben saham kanggo taun ngarep

Logo grafis Exagen Inc. (XGN)

Exagen Inc. central laboratories ensure high throughput through the calibration of automated processors. Current expectations for the eps n+1 growth rate confirm this efficiency, with the level sitting around 24.10. Supply chain reliability is guaranteed by the express delivery of biomaterials, while an academic approach and rising salaries enable the retention of leading specialists in the field of autoimmune pathology diagnostics.

XGN: Prakiraan wutah bathi kanggo taun ngarep Exagen Inc 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan Exagen Diagnostics (XGN)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
Analisis umum perusahaan:Exagen Inc
Produk dadi Exagen Inc

This indicator measures the expected earnings per share (EPS) dynamics, determining the future investment attractiveness and solvency of the issuer. Analyzing the one-year forward EPS growth rate allows for an assessment of the analysts' consensus forecast regarding the scaling pace of net income. Calculated levels are based on projected revenue minus operating expenses and tax liabilities. For Exagen Inc. (XGN), these expectations are supported by the inclusion of their tests in systemic lupus erythematosus diagnostic protocols.

Analisis pesaing Exagen Inc.

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Biotechnology - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep soterahealth.com|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPKO Health - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MDXH: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Insight Molecular|TRIB (Trinity Biotech) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep AIMD|Proyeksi tambahing bathi saben saham ing taun ngarep CODX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Heart Test Laboratories HSCS|BMRA: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|CDIO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Onconetix Corp (ONCO) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VRAX (Virax Biolabs Group Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|AXDX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep centogene.com (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Enzo Biochem|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep FRES|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep GTG Labs|23andMe Holding Co - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep